• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Dysphasia (2195); Insufficient Information (4580)
Event Date 03/14/2021
Event Type  Death  
Event Description
It was reported that the patient had a hematoma in the frontal lobe of the right hemisphere of their brain.The patient seemed confused and had a hard time finding words to communicate.The patient also had a blood disease, polycythemia vera, which gives a slightly increased risk of blood clots, and discreet parkinsons symptoms.Anticoagulation treatment was resumed after the first acute ct scan and infection rates showed no issues.The patient later experienced cramps in their left extremities, but it quickly subsided once they were given stesolid medication intramuscularly.Later that morning, the patient was found with pupil difference, snoring respiration, and was uncontactable.The patient had a second acute ct scan performed, which showed a very large amount of bleeding in relation to the lead in the right hemisphere.The physician noted that there was a breakthrough into the ventricular system and there were no neurosurgical treatment options.The patient was transferred to the icu before passing away.The official cause of death is large bleeding in relation to the lead in the frontal lobe of the right hemisphere with a breakthrough into the ventricular system.The complication occurred after a permanent implant procedure and prior to discharge.The leads will not be explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key11645576
MDR Text Key244786108
Report Number3006630150-2021-01342
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 04/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/13/2022
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7078784
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/15/2021
Initial Date FDA Received04/09/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-